Check out this morning’s top movers from around Wall Street, compiled by The Fly.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
HIGHER –
- Arrowhead (ARWR) up 22% after entering into a global licensing and collaboration agreement with Sarepta (SRPT) in which the company will receive $825M, consisting of $500M cash and $325M as an equity investment priced at a 35% premium
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
- Kohl’s (KSS) down 17%
- Titan Machinery (TITN) down 2%
- American Woodmark (AMWD) down 2%
- Best Buy (BBY) down 1%
- Burlington Stores (BURL) down 1%
- Abercrombie & Fitch (ANF) down 1%
- Manchester United (MANU) down 1%
LOWER –
- Amgen (AMGN) down 12% after reporting data at 52 weeks in a Phase 2 study with maridebart cafraglutide, an investigational antibody peptide conjugate subcutaneously administered monthly or less frequently for people living with obesity.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Sarepta to pay Arrowhead $500M + in licensing deal for siRNA-based treatments
- Arrowhead to get $825M in Sarepta licensing pact, appoints Sarepta CEO to board
- Options Volatility and Implied Earnings Moves This Week, November 25 – November 29, 2024
- ARWR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Arrowhead submits plozasiran NDA to FDA